Following the close of the transaction, Em-tec will become part of the PSG® business unit within Dover’s Pumps & Process Solutions segment.
Em-tec is headquartered in Finning, Germany, and has a 30-year history of producing innovative flow measurement equipment used in connection with cardiac, vascular and transplant surgery, dialysis and “life support” procedures, automated bioprocess monitoring, and laboratory and industrial processes where flexible tubing is used. Em-tec has pioneered non-invasive flow measurement using the ultrasound transit-time principle and its devices have demonstrated the ability to deliver superior measurement results relative to competing offerings.
The addition of Em-tec further expands Dover’s reach into biopharma and other hygienic applications and enhances its portfolio of flow control technologies with flow rate sensors. “We are excited to bring together Em-tec’s flow measurement devices and PSG’s Quattroflow™ pump technology to expand our offering to our customers in biopharma and medical applications,” said Richard J. Tobin, Dover’s President and Chief Executive Officer. “This transaction is another step in advancing Dover’s strategy of enhancing the quality of our portfolio with attractive bolt-on acquisitions that offer profitable growth runway and create value for our shareholders.”
Terms of the transaction were not disclosed. The transaction is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, and is expected to close in the second quarter of 2020.